Acesso de pessoas trans e travestis à profilaxia pré-exposição ao HIV no Brasil: estudo descritivo, 2018-2023
Authors:
- Aline Pilon Mauricio da SilvaASAline Pilon Mauricio da Silva
- Isabela Ornelas PereiraIPIsabela Ornelas Pereira
- Tatianna Meireles D. AlencarTATatianna Meireles D. Alencar
- Beatriz Brittes KamienskyBKBeatriz Brittes Kamiensky
- Marihá Camelo Madeira de MouraMMMarihá Camelo Madeira de Moura
- Francisco Álisson Paula de FrançaFFFrancisco Álisson Paula de França
- Thiago Cherem MorelliTMThiago Cherem Morelli
- Ana Roberta Pati PascomAPAna Roberta Pati Pascom
Open Access
- 1 January 2024
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 33 (spe1) , e2024322
Abstract
Objetivos Analisar o acesso à profilaxia pré-exposição ao HIV (PrEP) no Brasil, comparando-o entre população trans e cis.Keywords
This publication has 16 references indexed in Scilit:
- Barreiras para o uso da Profilaxia Pré-Exposição (PrEP) ao HIV: uma revisão integrativaRevista Brasileira de Enfermagem, 2023
- Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas studyJournal of the International AIDS Society, 2022
- Barreiras e facilitadores do acesso de populações vulneráveis à PrEP no Brasil: Estudo ImPrEP StakeholdersCadernos de Saude Publica, 2022
- The worldwide burden of HIV in transgender individuals: An updated systematic review and meta-analysisPLOS ONE, 2021
- Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP ImplementationClinical Infectious Diseases, 2020
- HIV Antiretroviral Treatment and Pre-exposure Prophylaxis in Transgender IndividualsDrugs, 2020
- Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT StudyClinical Infectious Diseases, 2018
- Rapidly declining HIV infection in MSM in central LondonThe Lancet HIV, 2017
- Effectiveness and safety of oral HIV preexposure prophylaxis for all populationsAIDS, 2016
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialThe Lancet, 2016